SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DUATTI, Adriano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.604
AS - Asia 8.508
EU - Europa 5.128
SA - Sud America 1.532
AF - Africa 195
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 9
Totale 31.000
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.257
SG - Singapore 3.213
CN - Cina 2.204
BR - Brasile 1.222
DE - Germania 908
VN - Vietnam 907
IT - Italia 843
UA - Ucraina 839
HK - Hong Kong 684
GB - Regno Unito 600
TR - Turchia 461
FI - Finlandia 392
PL - Polonia 383
SE - Svezia 327
FR - Francia 292
RU - Federazione Russa 207
IN - India 194
JP - Giappone 193
MX - Messico 149
CA - Canada 142
BD - Bangladesh 141
AR - Argentina 103
ID - Indonesia 92
ZA - Sudafrica 75
IQ - Iraq 69
NL - Olanda 59
ES - Italia 49
VE - Venezuela 48
BE - Belgio 47
PK - Pakistan 46
EC - Ecuador 43
UZ - Uzbekistan 42
CO - Colombia 37
PH - Filippine 33
AT - Austria 29
SA - Arabia Saudita 29
CH - Svizzera 25
IR - Iran 25
MA - Marocco 25
CZ - Repubblica Ceca 24
MY - Malesia 23
AU - Australia 22
CL - Cile 22
LT - Lituania 21
TN - Tunisia 21
PY - Paraguay 18
EG - Egitto 17
BG - Bulgaria 15
JO - Giordania 15
KE - Kenya 15
AE - Emirati Arabi Uniti 14
TW - Taiwan 14
JM - Giamaica 13
KR - Corea 12
UY - Uruguay 12
AZ - Azerbaigian 11
BO - Bolivia 11
IE - Irlanda 10
PE - Perù 10
KG - Kirghizistan 9
LB - Libano 9
NP - Nepal 9
RO - Romania 9
SY - Repubblica araba siriana 9
DZ - Algeria 8
HU - Ungheria 8
IL - Israele 8
PA - Panama 8
LV - Lettonia 7
OM - Oman 7
ET - Etiopia 6
EU - Europa 6
KZ - Kazakistan 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
AL - Albania 5
DO - Repubblica Dominicana 5
GR - Grecia 5
HN - Honduras 5
GT - Guatemala 4
GY - Guiana 4
MN - Mongolia 4
PS - Palestinian Territory 4
BY - Bielorussia 3
CG - Congo 3
CR - Costa Rica 3
GA - Gabon 3
KW - Kuwait 3
MK - Macedonia 3
NG - Nigeria 3
NI - Nicaragua 3
NO - Norvegia 3
PT - Portogallo 3
RS - Serbia 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GE - Georgia 2
Totale 30.957
Salva come PNG Salva come JPEG
Città #
Singapore 2.032
Ashburn 1.539
Woodbridge 1.167
Fairfield 1.165
San Jose 1.107
Houston 913
Jacksonville 848
Chandler 760
Ann Arbor 721
Santa Clara 673
Hong Kong 671
Beijing 588
Wilmington 502
Seattle 465
Warsaw 374
Cambridge 348
Ho Chi Minh City 290
Nanjing 264
Izmir 256
Los Angeles 248
Munich 237
New York 216
Ferrara 198
Princeton 195
Hanoi 188
Addison 186
Tokyo 184
Lauterbourg 167
The Dalles 161
Helsinki 157
Dallas 153
São Paulo 138
Milan 137
San Diego 114
Boardman 101
Falkenstein 97
Council Bluffs 96
Mexico City 96
Shenyang 94
Nanchang 80
Shanghai 79
Hefei 71
Tianjin 69
Orem 64
Buffalo 63
Turku 63
London 61
Dearborn 60
San Mateo 60
Falls Church 59
Dong Ket 57
Hebei 57
Changsha 54
Brooklyn 51
Chicago 51
Da Nang 49
Stockholm 45
Chennai 44
Redwood City 43
Jakarta 42
Montreal 42
Bremen 40
Denver 40
Johannesburg 40
Toronto 40
Brussels 39
Frankfurt am Main 38
Jiaxing 38
Rio de Janeiro 38
Tashkent 38
Amsterdam 37
Nuremberg 36
Atlanta 35
Moscow 35
San Francisco 35
Belo Horizonte 33
Bologna 33
Boston 33
Phoenix 33
Baghdad 32
Guangzhou 32
Poplar 32
Auburn Hills 28
Brasília 28
Haiphong 28
Jinan 28
Kunming 27
Ningbo 27
Washington 25
Zhengzhou 25
Curitiba 24
Norwalk 24
Mumbai 23
Dhaka 22
Rome 21
Des Moines 19
Padova 18
Querétaro 18
Vienna 18
Ankara 17
Totale 20.287
Salva come PNG Salva come JPEG
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 523
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 391
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 340
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 289
A solvent-extraction module for cyclotron production of high-purity technetium-99m 281
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 279
LARAMED: A Laboratory for Radioisotopes of Medical Interest 274
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma 272
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 253
YAP-(S)PET small animal scanner: Quantitative results 251
An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)]:(-) efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid 242
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 234
Technetium(V)-nitrido complexes of dithiocarbazic acid derivatives. Reactivity of (Tc=N)2+ core towards Schiff bases derived from S-methyl dithiocarbazate. Crystal structures of (S-methyl-3-(2-hydroxyphenyl-methylene) dithiocarbazato) nitrido (triphenylphosphine) Technetium(V) and bis(S-methyl-3- isopropylidene dithiocarbazato) nitrido Technetium(V). 232
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 231
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [Tc-99m(N) (PXP)](2+) (PXP = diphosphine ligand) 226
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 223
Synthesis and Structure of an Amino Sugar-Schiff Base Complex of Technetium(V) Containing Salicylaldehyde in an Unusual Coordination Mode 218
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 218
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 216
A small animal hybrid PET-SPECT scanner: First in-vivo results. 214
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 213
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 212
Formation of the Tc≡N multiple bond from the reaction of ammonium pertechnetate with S-methyl dithiocarbazate and its application to the preparation of technetium-99m radiopharmaceuticals 211
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 208
Radiofarmaci 207
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 206
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics 206
Tc(IV)Cl4(PPh3)2 and Tc(III)Cl3(CH3CN)(PPh3)2 as precursors of trans dioxo technetium(V) complexes with chelating amines and tetraazamacrocycles 204
Communicating across the boundaries 203
Extraction techniques of 99mTc from 100Mo Metal Target 200
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 199
Association of Co(sep)3+ ions with S2O32- ions: Spectrophotometric, circular dichroism and solubility measurements 199
Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands 198
Chemistry and Bifunctional Chelating Agents for Binding Lu-177 197
STRUCTURE OF TRANS-TRICHLOROBIS[DIETHYL(PHENYL)PHOSPHINE]HYDROXORHENIUM(IV) 196
Erratum: A kit formulation for the preparation of 188Re- lipiodol: Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma (Nuclear Medicine Communication (2004) 25 (691-699)) 194
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons 194
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 192
Design and synthesis of a redox-active Tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)-] 192
A Comparison of Separation and Purification Strategies for 51/52Mn cyclotron production 192
Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules 191
THE STRUCTURE OF TRANS-DIBROMOOXO(N-PHENYLSALICYLIDENEAMINATO)(TRIPHENYLPHOSPHINE)RHENIUM (V), FORM-II (TRICLINIC), [REBR2(C13H10NO)O(P(C6H5)3)] 188
Complexes of Tc(V) and Tc(III) with tridentate Schiff bases derived from S-Methyl dithiocarbazate. Crystal structures of chloro-[S-methyl-3-(2-hydroxy-1-naphtyl methylene) dithiocarbazato(2-)]oxotechnetium(V) and dichloro[S-methyl-3-(2-hydroxybenzilidene) dithiocarbazato(1)]bis (triphenylphosphine) technetium(III). 188
Isolation and Crystal Structure of a Technetium(V) Nitrido Complex Containing a Coordinated Transient State of N-(2-Aminoethyl)carbamic Acid 185
Synthesis, reactivity and X-ray crystal structures of mixed thiazolato- or carboxylato-carbonyl(phosphine)-rhenium(I) complexes 185
Molecular imaging with endogenous and exogenous ligands: the instance of antibodies, peptides, iodide and cupric ions 185
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 184
Synthesis, properties and X-ray crystal structure of Schiff base organo-imido complexes of rhenium(V) 182
188W/188Re generator system and its therapeutic applicacions 182
The chemistry of heteroallyl derivatives of technetium. Reactivity of [TcNCl2(PPh3)2] and [Tc(CO) 3Cl(PPh3)] with thiazetidine ligands, crystal structures of [Tc(CO)2(PPh3)2{PhN=C(OEt)S}] and [TcN(Cl)(PPh3)-{PhN=C(OEt)S}] 182
Cyclotron-Production of 51/52Mn Isotopes: the METRICS Project Final Report 181
A new efficient method for the preparation of 99mTc-radiopharmaceuticals containing the TcN multiple bond 180
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 180
Photochemical synthesis and reaction of d6 metallocenes—tetracyanoethylene charge-transfer complexes 179
Crystal structure of trans-dicarbonylbis (dimethylphenylphoshine)(N-phenylsalicyl ideneaminato) rhenium(I) and mer-trichloro (dimethylphenylphosphine)(N-phenylsalicyl ideneaminato) rhenium(IV). Comparison of Re(I), Re(III), Re(IV) and Re(V) complexes with salicylideneaminato ligand and reaction mechanism. 179
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 179
A class of asymmetrical nitrido Tc-99m heterocomplexes as heart imaging agents with improved biological properties 177
Synthesis and X-ray crystal structure of the mixed organoimido, organoamine rhe-nium(V) complex [ReCl3(NC6H4Me-p)(NH2C6H4Me-p)PPh3] 175
Synthesis of Technetium(V)-Nitrido Complexes with Chelating Amines: A Novel Class of Monocationic, Octahedral Complexes Containing the [Tc≡N]2+ Core. Crystal Structures of [TcN(en)2Cl]+ (en = Ethylenediamine) and [TcN(tad)Cl]+ (tad = 1,5,8,12-T etraazadodecane) 175
Esophageal substitute using the Sparks prosthesis. Experimental study 175
Synthesis and characterization of technetium-(IV) and -(III) complexes with bidentate Schiff bases. X-ray molecular structure of chloro(dimethylphenylphosphine)bis(N-phenylsalicylideneiminato)technetium(III) 174
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 174
Advances in radiopharmaceuticals for cardiac imaging: 99mTcN-NOET 174
RHENIUM(V) COMPLEXES WITH VINYL AMIDES 173
Synthesis and characterization of paramagnetic schiff base complexes of rhenium(IV) 172
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)](2+) metal fragments (M = Tc, Re; PXP = diphosphine ligand) 172
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies 172
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 172
Clearance of technetium 99m N-NOET in normal, ischemic-reperfused, and membrane-disrupted myocardium 171
Asymmetrical nitrido Tc-99m heterocomplexes: A class of cardiac agents with unprecedented imaging properties. 170
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 169
Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties 169
Synthesis and x-ray crystal structure of the mixed organoimido, organoamine rhenium(V) complex ReCl3(NC6H4Me-p)(NH2C6H4Me-p)PPh3] 168
Technetium(V)-nitrido complexes of dithiocarbazic acid derivatives. Reactivity of [Tc≡N]2+ core towards Schiff bases derived from S-methyl dithiocarbazate. Crystal structures of [S-methyl 3-(2-hydroxyphenylmethylene)dithiocarbazato]nitrido(triphenylphos-phine)technetium(V) and bis(S-methyl 3-isopropylidenedithiocarbazato)nitridotechnetium(V) 168
The chemistry of heteroallene and heteroallyl derivatives of rhenium. Part 1. Reactiv-ity of mixed carbonyl(formamido)(phosphine)rhenium(I) complexes with RNCS (R = Ph or p-MeC6H4) and PhNCO. Crystal structure of the thiazetidine rhenium(I) com-plex [Re(CO)2(PPh3)2PhN=C(OEt)-S] 167
Reactions of the Technetium(I) Carbonyl Complexes [Tc(PMe2Ph)3(CO)2Cl] and [Tc(PPh3)2(CO)3Cl] toward Pseudoallyl Ligands Such as Triazenido, Formamidinato, and Acetamidinato. Crystal Structures of [Tc(PMe2Ph)2(CO)2(p-CH3C6H4N-N-NC6H4CH3-p)] and [Tc(PMe2Ph)2(CO)2(C6H5N-C(CH3)-NC6H5)] 166
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 166
Cyclotron-Production of 51/52Mn Isotopes: An Update on the METRICS Project 166
Technetium(V) nitrido complexes with tetra-azamacrocycles: monocationic and neu-tral octahedral complexes containing the [Tc≡N]2+ core. Crystal structure of [TcN(L1)(H2O]·2H2O (H2L1 = 1,4,8,11-tetra-azacyclotetradecane-5,7-dione) 163
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 162
Bis(dithiocarbamato) nitrido technetium-99m radiopharmaceuticals: A class of neutral myocardial imaging agents 161
PREPARATION AND CHARACTERIZATION OF MIXED AMIDO, CARBOXYLATO OR THIAZOLATO CARBONYL(PHOSPHINE)TECHNETIUM(I) COMPLEXES 161
Technetium and rhenium heterocomplexes containing the diphenylphosphinoferrocenyl fragment 161
POLAROGRAPHIC AND SPECTROPHOTOMETRIC INVESTIGATION OF THE REDUCTION AND DEPROTONATION OF (1,3,6,8,10,13,16,19-OCTA-AZABICYCLO-[6,6,6]-ICOSANE)COBALT(III) ION, CO(SEP)3+, IN THE PRESENCE OF DIFFERENT ANIONS 161
Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites 161
Crystal structures of trans-dicarbonylbis(dimethylphenylphosphine)(N-phenylsalicyl-ideneaminato)rhenium(I) and mer-trichloro(dimethylphenylphosphine)(N-phenyl-salicylideneaminato)rhenium(IV). Comparison of ReI, ReIII, ReIV, and ReV complexes with salicylideneaminato ligand and reaction mechanisms 160
Technetium-99m nitrido radiopharmaceuticals with unprecedented biological properties 160
Reactivity of rhenium(I) pseudo-allyl complexes with heterocumulenes. Part 2. Inser-tion reactions. Crystal structures of the thiazolyl-thioureido and -dithiocarbamato complexes [Re(CO)2(PPh3)2SC(NPh)NMe(C3H2NS)] ·CH2Cl2 and [Re(CO)2(PPh3)2S2CNMe(C3H2NS)]·CH2Cl2 (C3H2NS = thiazol-2-yl) 159
Radiochemical Puritiy Of 99mTc-HMPAO: some Considerations on Routine Radiopharmaceuticals Preparation 157
Incorporation of a glucose moiety in a technetium-99m nitrido compound 156
Mixed schiff base, carbonyl(phosphine)rhenium(I) complexes 155
Technetium complexes and radiopharmaceuticals with scorpionate ligands 154
Labeling and biodistribution studies of Tc-99m radiopharmaceuticals with (o-hydroxyphenyl)diphenylphosphine 153
YAP-(S)PET: A hybrid PET-SPECT imager for small animal 153
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals 153
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP = heterodiphosphane) 153
In vivo imaging of oligonucleotides with nuclear tomography 152
Nonisotopic substitution: Is fluorine a replacement for hydrogen? 150
Synthesis and labelling with the [99mTcN]2+ core of macromolecular multifunctional ligands for sentinel limphnode detection 149
The IART approach: new Re-188 nitrido biotinilated radiopharmaceuticals useful for cancer therapy 149
Totale 19.568
Salva come PNG Salva come JPEG
Categoria #
all - tutte 139.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.353
Totale 152.272
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021163 0 0 0 0 0 0 0 0 0 0 0 163
2021/20222.175 79 200 169 95 141 75 90 122 81 158 287 678
2022/20231.758 211 123 44 220 250 273 102 148 189 22 125 51
2023/2024968 91 113 81 39 63 104 71 64 19 28 29 266
2024/20254.825 137 94 332 148 510 312 246 358 724 609 909 446
2025/202611.428 1.129 432 916 1.600 1.771 777 1.291 710 1.031 1.257 384 130
Totale 31.301